What Is AVDE? Avantis International Equity ETF

Most international equity funds have a recognisable top of the book: a handful of European and Japanese giants at three or four percent each. AVDE does not. ASML at 1.6% is the only holding above one percent among the top ten, and the list tails off quickly to Allianz and UBS at 0.5%. The ten together account for roughly 7.5% of assets.

That shape is the direct result of the strategy. Avantis starts from a broad developed-markets universe and then adjusts weights toward companies that are smaller, cheaper relative to book value, and more profitable. Every one of those tilts pushes money away from the largest names and spreads it across a long tail. The fund is active in the regulatory sense, with no index to track, but the activity is a set of rules applied to thousands of positions rather than a concentrated set of convictions.

The practical consequence is that no single company can move the fund. The flip side is that the fund will not keep pace with a market where a few very large international names are doing all the work, because by design it holds less of them than a cap-weighted alternative would.

Financials at 25% and industrials at 20% make up nearly half the portfolio, while technology sits at 9%, materials at 10% and consumer discretionary at 9%. Compare that to a US fund, where technology alone often exceeds forty percent, and the difference in what you are actually buying becomes clear.

Part of this is simply what developed markets outside the US contain. European and Japanese indices are heavy in banks, insurers, industrial machinery and materials, and light in the platform technology companies that dominate American benchmarks. The rest comes from the value tilt, which systematically underweights the expensive end of any market, and the expensive end of international markets tends to be technology and luxury consumer names.

The top holdings show this in practice. ASML aside, the list runs through Roche, HSBC, Shell, Safran, Novartis, BBVA, BHP, Allianz and UBS: pharmaceuticals, banks, energy, aerospace and mining. Note that several are held through US-listed depositary receipts while others sit as local lines, which affects nothing economically but explains the mixed ticker formats in published holdings files.

At 0.23%, AVDE prices close to a plain index fund while running a rules-based active mandate. That gap between active fee and index-like cost is the reason the fund has gathered $17.2B since 2019. It is not free, though: the cheapest passive developed-markets funds charge less, and the value and profitability tilts are exactly the sort of thing that can lag a cap-weighted benchmark for years at a stretch.

The 2.47% yield is higher than a cap-weighted developed-markets fund would typically produce, because banks, energy and insurers pay more of their earnings out than technology companies do. That income is a consequence of the tilts, not a target of the strategy, and it is not designed to be stable.

AVDE is a poor fit for someone who wants their international allocation to mirror the market, since the deviations from cap weighting are deliberate and persistent. It is also the wrong tool if you want emerging markets, which the developed-markets mandate excludes. Someone who already holds a small-cap value fund internationally will find meaningful overlap in the tilts, if not in the individual names.

Approximate weights as of August 2026. Each ticker links to its individual stock guide in Walnut.

There are three common ways to get AVDE exposure. Buy shares (or fractional shares) of AVDE directly at any major broker that lists it. Hold it as a core position and layer more concentrated ideas on top. Or build it into a thematic portfolio in Walnut, so AVDE sits alongside other holdings that express the same thesis, with target weights you can rebalance toward. AVDE trades like a stock during market hours, so you buy it the same way you would any listed share.

New to buying funds? See how to buy an ETF, step by step.

Whether AVDE is a good buy depends less on any single call and more on your time horizon and what you already hold: it tracks Actively managed, no tracked index, so the real question is whether you want that exposure in your mix and at what weight. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is AVDE a buy?

AVDE gives you Actively managed, no tracked index exposure in one ticker at a 0.23% expense ratio. Most investors use it as a core holding and layer more concentrated thematic portfolios on top.

Whether AVDE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is AVDE a buy?

AVDE yields 2.47% as of August 2026, paid by passing through the dividends of its underlying holdings. For the payout schedule, history, and how the distributions are taxed, see AVDE dividend: yield and schedule.

New to funds like AVDE? Start with what an ETF is, then how to buy an ETF, or browse the full guide to ETF investing.